- Home
- Supplements
- NADH
- Chronic Fatigue Syndrome (ME/CFS)
NADH for Chronic Fatigue Syndrome (ME/CFS)
One small randomized trial found that 10-20 mg/day of stabilized NADH reduced chronic fatigue syndrome symptom severity compared with placebo, and NADH is mechanistically plausible given the mitochondrial dysfunction reported in ME/CFS. However, this remains a single small trial awaiting replication.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 10-20 mg stabilised NADH daily, taken on an empty stomach in the morning
- Expected timeframe
- 4-12 weeks
Protocol
- form
- Enteric-coated stabilised NADH - unprotected NADH degrades in stomach acid
- duration
- 8-12 weeks
- co factor
- Take on an empty stomach and not in the evening, since it can be activating. Evidence is mixed: small trials report modest fatigue-score improvement, but the studies are short and largely industry-supported. Pacing remains the core of management.
- titration
- Increase to 20 mg daily after four weeks if there is no response; some CFS trials combined 20 mg NADH with 200 mg coenzyme Q10
- starting dose
- 10 mg on rising, at least 30 minutes before food
Evidence
What the studies say
The use of stabilized NADH in chronic fatigue syndrome: a randomized, double-blind, placebo-controlled study
Forsyth LM, Preuss HG, MacDowell AL
31% of chronic fatigue syndrome patients responded to NADH versus 8% on placebo over four weeks.
Coenzyme Q10 plus NADH supplementation in chronic fatigue syndrome: a randomized controlled trial
Castro-Marrero J, Saez-Francas N, Segundo MJ
CoQ10 plus NADH reduced maximum heart rate during exercise and improved fatigue scores versus placebo.
Effect of coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in myalgic encephalomyelitis/chronic fatigue syndrome
Castro-Marrero J, Segundo MJ, Lacasa M
Eight weeks of CoQ10 plus NADH significantly reduced fatigue perception and improved sleep and quality of life.
Safety
Caveats
Improved energy must not be spent exceeding the activity envelope - overexertion causes post-exertional crashes. Reported effects include jitteriness, insomnia if taken late, and loss of appetite. Safety ceiling: doses above 20 mg/day have not been evaluated. No pregnancy or breastfeeding safety data - avoid. Exclude anaemia, thyroid disease, sleep apnoea and coeliac disease before attributing fatigue to CFS.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.